Trial intelligence / Profile preview

Insulin sensitivity after conversion from twice-daily tacrolimus to extended-release once-daily tacrolimus in stable renal transplant recipients

TCTR20151005001Phase 4Completed

Sponsor
Prajej Ruangkanchanasetr
Start
Jan 2015
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in Kidney allograft status (RTx), sponsored by Prajej Ruangkanchanasetr. Started Jan 2015; status: completed.

02

Drugs

tacrolimus
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on TCTR20151005001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20151005001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call